FDA Press Announcements

The Food and Drug Administration regulates the safety and efficacy of drugs, medical devices, food, dietary supplements, and tobacco products.

The Food and Drug Administration (FDA) is a federal agency within the Department of Health and Human Services responsible for regulating the safety, efficacy, and labeling of drugs, biological products, and medical devices; ensuring the safety of the nation's food supply and dietary supplements; regulating the manufacture, marketing, and sale of tobacco products; and overseeing other products under its jurisdiction. The FDA reviews and approves new drugs and medical devices before they can be marketed, based on evidence of safety and efficacy submitted by manufacturers. The agency monitors the safety of products already on the market through adverse event reporting systems, inspection programs, and post-market surveillance, and investigates reports of product defects or safety concerns. When products are found to pose risks to public health, the FDA may request or require recalls, issue warnings, or take enforcement actions. The agency also establishes and enforces standards for food production, manufacturing, labeling, and safety, inspects food facilities, and works with state and local authorities on food safety. The FDA's press office announces new drug approvals and medical device clearances, product recalls and safety warnings, enforcement actions taken against manufacturers or distributors, public health advisories, guidance documents, and policy announcements. Readers of FDA press releases in this digest will see announcements of FDA approval of new medications or medical devices, notices of product recalls due to safety defects or contamination risks, enforcement actions taken against companies for regulatory violations, public health warnings or advisories issued by the agency regarding risks associated with specific products or practices, recalls of food products due to contamination or safety concerns, and information about FDA policies and regulatory initiatives. The press feed carries descriptions of recent announcements, with full article texts providing additional detail and context. FDA materials document the agency's regulatory activities and public health actions and provide information about the government's oversight of drugs, medical devices, food, dietary supplements, and tobacco products.

Model-written orientation, generated 2026-08-04 by haiku, prompt version 1. It may draw on general knowledge of public institutions and is not official-record content.

We poll the FDA press announcements RSS feed and retrieve full article text from each item's linked page. The feed delivers teasers of approximately 230 characters; extracted text from articles ranges from 5,196 to 7,905 characters, with a median of 6,380 characters. Over the past 14 days, we observed 6 items at a rate of 0.43 per day, an increase from the previous measurement's 0.36 per day. The most recent item dates to September 15, representing a resumption of deliveries after an 8-day quiet period noted in the prior assessment. Our polling requests achieved a 100% success rate, with all 356 requests to www.fda.gov returning content, improving from the prior period when one request returned no content. Polling maintains a consistent hourly cadence throughout the measurement window. An associated email-based FDA source continues to operate in parallel.

Model-written assessment of our own ingestion, generated 2026-09-16 by haiku, prompt version 1, trigger: health-change. It restates our measured figures and is not official-record content.